MedPath

Assessment of the Effect of Output on New Adhesives

Not Applicable
Completed
Conditions
Ileostomy - Stoma
Interventions
Other: Standard hydrocolloid adhesive patch
Other: LT-2
Other: LT-21
Other: 33-20
Registration Number
NCT03331783
Lead Sponsor
Coloplast A/S
Brief Summary

The study investigates the impact real output has on adhesion of new adhesives

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Have given written informed consent
  • Be at least 18 years of age and have full legal capacity
  • Have had a stoma for more than one year
  • Have intact skin on the area used in the evaluation
  • Has a stoma with a diameter up to (≤) 35 mm
  • Have a peristomal area accessible for application of patches/adhesive strips (assessed by investigating scientist)
Exclusion Criteria
  • Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  • Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
  • Are pregnant or breastfeeding
  • Having dermatological problems in the peri-stomal- or abdominal area (assessed by investigating scientist)
  • Actively participating in other interventional clinical investigations or have previously participated in this investigation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test of new adhesive stripsStandard hydrocolloid adhesive patchOn the peristomal skin 4 different patches are applied to the skin (Standard hydrocolloid adhesive patch; LT-2, LT21 and 33-20. There is a bag welded to each patch. Tthe bag contains real output. The difference between the four patches is that they are made of four different adhesives. The primary endpoint is measured after 8 hours and 24 hours.
Test of new adhesive strips33-20On the peristomal skin 4 different patches are applied to the skin (Standard hydrocolloid adhesive patch; LT-2, LT21 and 33-20. There is a bag welded to each patch. Tthe bag contains real output. The difference between the four patches is that they are made of four different adhesives. The primary endpoint is measured after 8 hours and 24 hours.
Test of new adhesive stripsLT-21On the peristomal skin 4 different patches are applied to the skin (Standard hydrocolloid adhesive patch; LT-2, LT21 and 33-20. There is a bag welded to each patch. Tthe bag contains real output. The difference between the four patches is that they are made of four different adhesives. The primary endpoint is measured after 8 hours and 24 hours.
Test of new adhesive stripsLT-2On the peristomal skin 4 different patches are applied to the skin (Standard hydrocolloid adhesive patch; LT-2, LT21 and 33-20. There is a bag welded to each patch. Tthe bag contains real output. The difference between the four patches is that they are made of four different adhesives. The primary endpoint is measured after 8 hours and 24 hours.
Primary Outcome Measures
NameTimeMethod
Trans epidermal water loss8 hours

The trans epidermal water loss is measured on the peristomal skin using a probe. The trans epidermal water loss is a measure for the skins barrier function. There is always a loss of water from the skin due to natural evaporation. However, when the skin barrier is damaged the evaporation will increase leading to an increase in the trans epidermal water loss.Thus, trans epidermal water loss is used to assess the damage to the skin. Maesurents are taken at time 0 and after 8 hours of output exposure to the skin.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Coloplast A/S

🇩🇰

Humlebæk, Denmark

© Copyright 2025. All Rights Reserved by MedPath